National
A new era begins for HRC under Chad Griffin
Immediate challenges include ballot measures, re-electing Obama
Incoming HRC President Chad Griffin (Photo courtesy of AFER)
After seven years leading the Human Rights Campaign, Joe Solmonese steps down next week, bringing change to the nation’s largest LGBT rights organization just five months before a critical presidential election.
On Monday, Chad Griffin will officially take over as president of HRC, which, with an annual budget of $40 million and about 150 full-time employees, is often seen as the political and cultural lead for the LGBT community. Griffin was named HRC’s new leader in March and replaces Solmonese, who has headed the organization since March 2005.
Solmonese saw many historic and positive changes for the LGBT community in his seven years at the helm. Among them are the defeat of the Federal Marriage Amendment during the Bush years, the fight to repeal “Don’t Ask, Don’t Tell” and, most recently, the first sitting U.S. president coming out in support of same-sex marriage.
Major challenges await Griffin, including the effort to re-elect President Obama, who has already won HRC’s endorsement. Also ahead, fights over marriage on the ballot in Minnesota, Maine, Maryland and Washington State as well as pursuing long-awaited federal employment non-discrimination protections for LGBT people.
Will Griffin take HRC in a new direction or bring a different style of leadership? The organization has often been criticized in the blogosphere for being too timid in taking on the Democratic establishment and not representing the “queer” faction of the LGBT community. Will the new leadership foster a new perception of the organization?
Griffin is best known for his work as board chair of the American Foundation for Equal Rights and its federal lawsuit challenging California’s Proposition 8, but he’s also had an extensive career fighting for progressive causes. According to his bio on AFER’s website, Griffin is founding partner of political and communications strategy firm Griffin-Schake, and taken on the tobacco and oil industries while advocating for issues such as clean energy, universal health care, stem cell research and early childhood education.
Another open question sparking plenty of speculation concerns HRC’s staffing. Will Griffin bring in his own people as he takes the helm? Some staffers — including David Smith, HRC’s vice president of programs — have been working in the LGBT rights movement since the early 1990s. It’s possible other HRC staffers may take Solmonese’s exit as a cue to make their own departure.
Both Solmonese and Griffin were unavailable for interviews for this article. LGBT rights advocates had different takes on their predictions for the leadership style of Griffin compared to Solmonese.
Winnie Stachelberg, vice president of external affairs at the Center for American Progress, called Griffin a “stupendous choice” and a “passionate advocate … for the range of issues that confront our community,” but characterized the new leadership as a continuation of the work seen under Solmonese.
“We’re not pivoting,” Stachelberg said. “It’s not as if we’ve moved from a leadership style of Joe Solmonese and we’re moving to the leadership style of Chad Griffin. What I think is encouraging about the shift from Joe to Chad is just the leadership that both of them have, the respect that both of them have — not only in the LGBT community, but in the progressive community more broadly.”
Michael Petrelis, a gay San Francisco-based blogger who has criticized HRC, was skeptical of any change and remained critical of HRC, calling the organization “an elitist social network known more for opening LGBT checkbooks for Democrats” than being interested in engaging with the larger LGBT community.
Among the goals that Petrelis called on Griffin to pursue at HRC were his plan for regional town halls, transparency over board of directors meetings and decisions, greater engagement with grassroots activists and ordinary LGBT people as well as a “commitment to members of the community who don’t want to get married or join the military.”
“The DNA of HRC is not wired to allow one man to change the institutional culture and I’ve heard nothing from Chad indicating that he wants to reform the organization,” Petrelis said. “All I expect of HRC regardless of who the executive leadership team comprises, is fealty to the Democratic Party and a commitment to keep the community from getting too pushy and uppity in demanding fierce advocacy and lasting change from our friends.”
But Stachelberg, formerly HRC’s political director, disputed the notion that HRC had been reluctant to criticize the Obama administration or Democratic leadership when the need arose.
“They’ve criticized the administration when they’ve seemed the most strategic, and they’ve worked with the administration and the Democratic establishment, as you call it, in lots of key ways,” Stachelberg said. “They don’t always agree with the Democratic leadership in the House and the Senate, and they make that clear. They don’t always agree with how a Democrat in a state operates, and I think they’ve made that clear.”
Steve Elmendorf, a gay Democratic lobbyist, said he hopes HRC will focus on the presidential election and making sure President Obama stays in the White House.
“We have a presidential campaign, with, I think, the clearest difference we’ve ever seen between two candidates,” Elmendorf said. “I think there are obviously other priorities in the House and the Senate and the ballot initiatives, but I think that the community — and I don’t speak for HRC — but I hope that its No. 1 goal between now and Election Day is to make sure that Barack Obama wins.”
In the long term, Elmendorf said the LGBT rights movement must reach out to public officials who’ve been on the fence about LGBT support — especially Republicans.
“I think that a lot of politicians, particularly on the Republican side, are behind where the voters are,” Elmendorf said. “I think Barack Obama and gay marriage was hugely important and symbolic. We have to grow that on the other side, though. We have to get some Republicans to step out and show that it’s OK to be on the correct side on our issues, and you can do that and get re-elected.”
Elmendorf said he’s been a fan of HRC under the leadership of Solmonese and doesn’t think anything is wrong with the organization, but acknowledged that “all organizations need to periodically change leadership and look internally at themselves and see how they can do a better job.”
“The world is changing on our issues and I think every year or two years organizations need to look at how the world is changing and figure out how we can do a better job,” he said.
Griffin has already taken a more aggressive stance in pushing public officials to support marriage equality even before he’s officially assumed his duties. Last month, after Vice President Joe Biden said on NBC’s “Meet the Press” that he’s “absolutely comfortable” with married gay couples having the “same exact rights” as straight couples — which many media outlets reported as support for marriage equality — Solmonese issued a statement saying he’s “encouraged” by Biden’s comments without explicitly calling it an endorsement.
But Griffin went a step further, telling media outlets that without a doubt Biden’s remarks were an endorsement of marriage equality. In an interview with the Washington Post, Griffin said “only in Washington and only in politics could someone parse the words of what the vice president said” and Biden was “very clear and very direct when asked if he was comfortable with gay marriage.”
Obama came out for same-sex marriage days later and Biden’s remarks have since been interpreted as an endorsement of marriage rights for gay couples (prompting Biden reportedly to apologize to the president for stepping out ahead of the president). Following Obama’s endorsement of marriage, Griffin issued another statement through HRC calling on members of Congress to follow the president’s lead.
“The American public has expressed interest in where their elected officials stand on the issue of marriage for gay and lesbian couples,” Griffin said. “The president has had the courage and integrity to speak out for marriage equality. Now is the time for members of Congress to do so too.”
Shortly thereafter, some public officials followed suit, including House Democratic Whip Steny Hoyer (D-Md.), Assistant Minority Leader Jim Clyburn (D-S.C.) and Illinois Gov. Pat Quinn (D).
John Aravosis, editor of AMERICAblog, said Griffin has already demonstrated considerable skill as an activist, but said keeping up his effectiveness will be challenging after he officially assumes his new duties.
“Chad has proven himself an effective activist with proven political smarts,” Aravosis said. “The challenge for Chad will be maintaining his scrappy effectiveness while at the helm of a large organization not always known for being nimble and edgy. I think it can be done, but he’ll have his work cut out for him.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
